Anti-tumour drug developer Tot Biopharm files for Hong Kong IPO

Anti-tumour drug developer Tot Biopharm files for Hong Kong IPO

Tot Biopharm general manager Gloria Huang

Chengwei CapitalTot Biopharm

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.